RITALIN

That this House notes that a 16 year study of the outcome of the use of Ritalin on children concluded that over a three-year period it produced no demonstrable improvement in children's behaviour, but that this amphetamine-type drug stunted growth; notes that the prescription of Ritalin has increased threefold since 1999 at a current cost to the NHS of £28 million; and calls for the transfer of this sum to therapies that are beneficial.